{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T08:19:14Z","timestamp":1778228354342,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Ministry of Health, Labour and Welfare, Japan","award":["21AA2007 and 22AA2003"],"award-info":[{"award-number":["21AA2007 and 22AA2003"]}]},{"name":"the Ministry of Health, Labour and Welfare, Japan","award":["21AA2007 and 22AA2003"],"award-info":[{"award-number":["21AA2007 and 22AA2003"]}]},{"DOI":"10.13039\/501100001700","name":"the Ministry of Education, Culture, Sports, Science and Technology, Japan","doi-asserted-by":"crossref","award":["20H03907"],"award-info":[{"award-number":["20H03907"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-023-05302-8","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T05:02:48Z","timestamp":1698901368000},"page":"415-424","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Association between aspirin dose and outcomes in patients with acute Kawasaki disease: a nationwide retrospective cohort study in Japan"],"prefix":"10.1007","volume":"183","author":[{"given":"Takanori","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuaki","family":"Michihata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsushi","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyoshi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyohide","family":"Fushimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Yasunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"issue":"14","key":"5302_CR1","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1016\/j.jacc.2015.12.073","volume":"67","author":"JW Newburger","year":"2016","unstructured":"Newburger JW, Takahashi M, Burns JC (2016) Kawasaki disease. J Am Coll Cardiol 67(14):1738\u20131749. https:\/\/doi.org\/10.1016\/j.jacc.2015.12.073","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"5302_CR2","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"BW Mccrindle","year":"2017","unstructured":"Mccrindle BW, Rowley AH, Newburger JW et al (2017) Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135(17):e927\u2013e999. https:\/\/doi.org\/10.1161\/CIR.0000000000000484","journal-title":"Circulation"},{"key":"5302_CR3","unstructured":"Miura M, Ayusawa M, Ito S (2020) The guidelines on acute stage Kawasaki disease treatment. Pediatr Cardiol Card Surg 36(suppl 1):S1.1-S1.29"},{"issue":"6","key":"5302_CR4","doi-asserted-by":"publisher","first-page":"e689","DOI":"10.1542\/peds.2004-1037","volume":"114","author":"KS Hsieh","year":"2004","unstructured":"Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM (2004) Treatment of acute Kawasaki disease: aspirin\u2019s role in the febrile stage revisited. Pediatrics 114(6):e689\u2013e693. https:\/\/doi.org\/10.1542\/peds.2004-1037","journal-title":"Pediatrics"},{"issue":"12","key":"5302_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144603","volume":"10","author":"HC Kuo","year":"2015","unstructured":"Kuo HC, Lo MH, Hsieh KS, Guo MMH, Huang YH (2015) High-dose aspirin is associated with anemia and does not confer benefit to disease outcomes in Kawasaki disease. PLoS One Woo PC (ed) 10(12):e0144603. https:\/\/doi.org\/10.1371\/journal.pone.0144603","journal-title":"PLoS One Woo PC (ed)"},{"issue":"6","key":"5302_CR6","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-0098","volume":"139","author":"F Dallaire","year":"2017","unstructured":"Dallaire F, Fortier-Morissette Z, Blais S et al (2017) Aspirin dose and prevention of coronary abnormalities in Kawasaki disease. Pediatrics 139(6):e20170098. https:\/\/doi.org\/10.1542\/peds.2017-0098","journal-title":"Pediatrics"},{"key":"5302_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jpeds.2016.12.019","volume":"184","author":"GB Kim","year":"2017","unstructured":"Kim GB, Yu JJ, Yoon KL et al (2017) Medium- or higher-dose acetylsalicylic acid for acute Kawasaki disease and patient outcomes. J Pediatr 184:125-129.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2016.12.019","journal-title":"J Pediatr"},{"issue":"5","key":"5302_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217274","volume":"14","author":"X Zheng","year":"2019","unstructured":"Zheng X, Yue P, Liu L et al (2019) Efficacy between low and high dose aspirin for the initial treatment of Kawasaki disease: current evidence based on a meta-analysis, editor. PLoS ONE 14(5):e0217274. https:\/\/doi.org\/10.1371\/journal.pone.0217274","journal-title":"PLoS ONE"},{"issue":"8","key":"5302_CR9","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1093\/rheumatology\/keaa050","volume":"59","author":"X Jia","year":"2020","unstructured":"Jia X, Du X, Bie S, Li X, Bao Y, Jiang M (2020) What dose of aspirin should be used in the initial treatment of Kawasaki disease? A meta-analysis Rheumatol (Oxf Engl) 59(8):1826\u20131833. https:\/\/doi.org\/10.1093\/rheumatology\/keaa050","journal-title":"A meta-analysis Rheumatol (Oxf Engl)"},{"issue":"7","key":"5302_CR10","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1002\/art.24660","volume":"60","author":"AC Lau","year":"2009","unstructured":"Lau AC, Duong TT, Ito S, Yeung RSM (2009) Intravenous immunoglobulin and salicylate differentially modulate pathogenic processes leading to vascular damage in a model of Kawasaki disease. Arthritis Rheum 60(7):2131\u20132141. https:\/\/doi.org\/10.1002\/art.24660","journal-title":"Arthritis Rheum"},{"issue":"2","key":"5302_CR11","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00246-014-1010-7","volume":"36","author":"T Nakada","year":"2015","unstructured":"Nakada T (2015) Effects of anti-inflammatory drugs on intravenous immunoglobulin therapy in the acute phase of Kawasaki disease. Pediatr Cardiol 36(2):335\u2013339. https:\/\/doi.org\/10.1007\/s00246-014-1010-7","journal-title":"Pediatr Cardiol"},{"issue":"4","key":"5302_CR12","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1542\/peds.2009-3266","volume":"126","author":"TD Simon","year":"2010","unstructured":"Simon TD, Berry J, Feudtner C et al (2010) Children with complex chronic conditions in inpatient hospital settings in the United States. Pediatrics 126(4):647\u2013655. https:\/\/doi.org\/10.1542\/peds.2009-3266","journal-title":"Pediatrics"},{"issue":"1","key":"5302_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12873-019-0282-x","volume":"19","author":"T Yumoto","year":"2019","unstructured":"Yumoto T, Naito H, Yorifuji T, Aokage T, Fujisaki N, Nakao A (2019) Association of Japan Coma Scale score on hospital arrival with in-hospital mortality among trauma patients. BMC Emerg Med 19(1):65. https:\/\/doi.org\/10.1186\/s12873-019-0282-x","journal-title":"BMC Emerg Med"},{"issue":"1","key":"5302_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/sim.2331","volume":"25","author":"P Royston","year":"2006","unstructured":"Royston P, Altman DG, Sauerbrei W (2006) Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med 25(1):127\u2013141. https:\/\/doi.org\/10.1002\/sim.2331","journal-title":"Stat Med"},{"issue":"9","key":"5302_CR15","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/sim.3841","volume":"29","author":"L Desquilbet","year":"2010","unstructured":"Desquilbet L, Mariotti F (2010) Dose\u2013response analyses using restricted cubic spline functions in public health research. Stat Med 29(9):1037\u20131057. https:\/\/doi.org\/10.1002\/sim.3841","journal-title":"Stat Med"},{"key":"5302_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3389\/fped.2020.00249","volume":"8","author":"Y Ito","year":"2020","unstructured":"Ito Y, Matsui T, Abe K et al (2020) Aspirin dose and treatment outcomes in Kawasaki disease: a historical control study in Japan. Front Pediatr 8:249. https:\/\/doi.org\/10.3389\/fped.2020.00249","journal-title":"Front Pediatr"},{"issue":"3","key":"5302_CR17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2739\/kurumemedj.37.203","volume":"37","author":"T Akagi","year":"1990","unstructured":"Akagi T, Kato H, Inoue O, Sato N (1990) A study on the optimal dose of aspirin therapy in Kawasaki disease\u2014clinical evaluation and arachidonic acid metabolism. Kurume Med J 37(3):203\u2013208. https:\/\/doi.org\/10.2739\/kurumemedj.37.203","journal-title":"Kurume Med J"},{"issue":"3","key":"5302_CR18","doi-asserted-by":"publisher","first-page":"182","DOI":"10.4070\/kcj.2013.43.3.182","volume":"43","author":"G Lee","year":"2013","unstructured":"Lee G, Lee SE, Hong YM, Sohn S (2013) Is high-dose aspirin necessary in the acute phase of Kawasaki disease? Korean Circ J 43(3):182\u2013186. https:\/\/doi.org\/10.4070\/kcj.2013.43.3.182","journal-title":"Korean Circ J"},{"key":"5302_CR19","doi-asserted-by":"publisher","unstructured":"Matsubara T, Mason W, Kashani IA, Kligerman M, Burns JC (1996) Gastrointestinal hemorrhage complicating aspirin therapy in acute Kawasaki disease. J Pediatr 128(5 Pt. 1):701\u2013703. https:\/\/doi.org\/10.1016\/s0022-3476(96)80140-5","DOI":"10.1016\/s0022-3476(96)80140-5"},{"issue":"5\u20136","key":"5302_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1440-1754.2005.00617.x","volume":"41","author":"CM Wei","year":"2005","unstructured":"Wei CM, Chen HL, Lee PI, Chen CM, Ma CY, Hwu WL (2005) Reye\u2019s syndrome developing in an infant on treatment of Kawasaki syndrome. J Paediatr Child Health 41(5\u20136):303\u2013304. https:\/\/doi.org\/10.1111\/j.1440-1754.2005.00617.x","journal-title":"J Paediatr Child Health"},{"issue":"1","key":"5302_CR21","first-page":"67","volume":"33","author":"JH Lee","year":"1992","unstructured":"Lee JH, Hung HY, Huang FY (1992) Kawasaki disease with Reye syndrome: report of one case. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 33(1):67\u201371","journal-title":"Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi"},{"issue":"9826","key":"5302_CR22","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0140-6736(11)61930-2","volume":"379","author":"T Kobayashi","year":"2012","unstructured":"Kobayashi T, Saji T, Otani T et al (2012) Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet 379(9826):1613\u20131620. https:\/\/doi.org\/10.1016\/S0140-6736(11)61930-2","journal-title":"Lancet"},{"issue":"10176","key":"5302_CR23","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/S0140-6736(18)32003-8","volume":"393","author":"H Hamada","year":"2019","unstructured":"Hamada H, Suzuki H, Onouchi Y et al (2019) Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial. Lancet 393(10176):1128\u20131137. https:\/\/doi.org\/10.1016\/S0140-6736(18)32003-8","journal-title":"Lancet"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-023-05302-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-023-05302-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-023-05302-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:15:48Z","timestamp":1707437748000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-023-05302-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["5302"],"URL":"https:\/\/doi.org\/10.1007\/s00431-023-05302-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3243710\/v1","asserted-by":"object"}]},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,2]]},"assertion":[{"value":"8 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Institutional Review Board of The University of\u00a0Tokyo (approval number: 3501-(3); 25 December 2017).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The requirement for informed consents was waived because of the anonymous nature of\u00a0the data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This paper did not include an individual\u2019s data or images.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}